RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma

NCT01047293 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: RAD001
DRUG: FOLFOX
DRUG: Bevacizumab

Sponsor

University of Utah

Collaborators

[object Object]